Navigation Links
Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics
Date:10/3/2008

Isis Pharmaceuticals, has developed and is commercializing the Ibis T5000(TM) Biosensor System for rapid identification and characterization of infectious agents. The Ibis T5000 is currently intended for research use only and not for use in diagnostic procedures. It is capable of identifying virtually all bacteria, viruses and fungi, and can provide information about drug resistance, virulence and strain type of these pathogens. Commercial applications for the Ibis T5000 Biosensor System include epidemiologic surveillance, monitoring of pandemic diseases, identification of emerging or previously unknown pathogens, forensic characterization of human samples, identification of sources of hospital-associated infections, and, in the future, human infectious disease diagnostics. Ibis develops, manufactures and markets Ibis T5000 instruments and assay kits. Additional information about Ibis can be found by selecting the Ibis link from Isis' homepage at http://www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Addit
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. SyntheMed Announces New Management Appointments
2. Alba Therapeutics Corporation Announces Promotions
3. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
4. 23andMe Announces Breast Cancer Initiative
5. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results
7. Synthetech Announces New Director of Manufacturing
8. Micromet Announces Definitive Agreement for $40 Million Private Equity Placement
9. Biotel Announces Record Revenues and Earnings for Fiscal 2008
10. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent
11. Helix BioPharma Announces $11.4 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 Nearly 600 medical r... funders today convened to explore novel developme... the inaugural Partnering for Cures meeting. ,...the Milken Institute, convened Partnering for Cur...ed to turn a scientific discovery into an accessib...
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
(Date:12/2/2009)..., Dec. 2 S*BIO Pte Ltd today annou...ibitor, SB1518, at The American Society of Hematol...ans. ,, Data will be presented on the clinical ...SB1518 detailing its safety, tolerability and phar...e levels ranging from 100 to 600 mg. These doses w...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- The world is going t... and uncertainty is part of many,businesses and in...s been,relatively immune to the economic downturn,... During the midst of the difficult times this ye... inaugurated an R&D center in Shanghai, the la...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...e quantities of difficult-to-express proteins ,...iochemical & Molecular Allergology, Research Cente...odonPlus(DE3)-RIL cells * with,extra copies of E...ossible to attain high-level expression of difficu...nduced expression of several recombinant peanut al...
...RoboCycler Gradient 96 temperature cycler ,,.... , Stratagenes RoboCycler Gradient 96 tempera...ed to perform fluorescent-tag cycle,sequencing u...ing,ready reaction kit. The new Hot Top Assembly...ays that hinder the loading of cycle sequencing re...
...,, Achieve superior transfection efficiencie...cott Basehore Jeff Braman ,Stratagene , Plasm...,EF plasmid midiprep kit, a kit based on anion e...um chloride density gradient centrifugation. Plasm...-nm optical density ratios) were comparable,with...
Other Biology Technology:High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4Automated Fluorescent-Tag Cycle Sequencing 2Automated Fluorescent-Tag Cycle Sequencing 3Automated Fluorescent-Tag Cycle Sequencing 4Automated Fluorescent-Tag Cycle Sequencing 5Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 2Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 3Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 4
(Date:12/3/2009)...design of the upcoming forest deal at Copenhagen i...to a scientist at the University of Leeds. , Wr...t at least 50% of the carbon credit payments to be...ssions from Deforestation and Degredation), should...operty rights assured. , "There is the potential...
(Date:12/3/2009)... U.S. Department of Energy,s (DOE) Brookhaven Nati...n Institute of Science has made a major step in un...mation in DNA that is necessary to carry out impor... in the December 1, 2009 edition of Nature Struct...eins responsible for interacting at specific sites...
(Date:12/2/2009)...no men have a more difficult time quitting smoking...ure, but acculturation has no affect on Latinas od...are published in Cancer Epidemiology, Biomarkers ...on for Cancer Research. The December issue has a s...s smoking cessation differently for Latino men and...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 1Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 3Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 4HealthLeaders InterStudy Unveils Enhanced Employer Vantage 49589 1HealthLeaders InterStudy Unveils Enhanced Employer Vantage 49589 2
... desperately try to reach for a break in the canop... affliction: Shade avoidance syndrome or SAS. Now,... light by researchers at the Salk Institute for Bi...rs shade, plants switch on a natural chemical fact...auxin that lets a plant grow and ultimately stretc...
...the inaugural conference of the iPlant Collaborati... virtual center in cyberspace for plant sciences r...itled "Bringing Plant and Computing Scientists Tog...nd scheduled for April 7-9, 2008, will take the fi...test unsolved mysteries its grand challenge quest...
... Society of Agronomy (ASA), Crop Science Society o...ica (SSSA) recognize the following undergraduate s... National Student Recognition Program announced in...ine. , The 2008 National Student Recognition Prog...s enrolled in agronomy, crop, soil, or environment...
Other Biology News:A place in the sun 2A place in the sun 3iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 2iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 3Outstanding undergraduates recognized in agronomy, crop, soil, and environmental sciences 2
...noCortin (POMC) has long been a molecule of fascin... of biologically-active peptides such as ACTH, -Li...mulating Hormone (a-MSH) and more. It is also a ve...rtebrates studied, including those "living fossils...
Mouse Anti-Rat Pan-NMDA NR1 Monoclonal Antibody, Unconjugated, Clone R1JHL from Calbiochem
BRASMC (B950-05) from European Collection of Cell Cultures (ECACC)
T4 DNA Ligase from Promega
Biology Products: